Phase 2 Rectal Cancer Recurrent Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations

Lung CancerMelanomaPancreas Cancer+4 more

N.N. Petrov National Medical Research Center of Oncology20 enrolled1 locationNCT06229340

Recruiting

Phase 2

Pencil Beam Proton Therapy for Pelvic Recurrences in Rectal Cancer Patients Previously Treated With Radiotherapy

Rectal Cancer Recurrent

University of Aarhus65 enrolled1 locationNCT04695782